LXEO

LXEO Change in Working Capital

-$17.11MTTM · USD

Period ending:

LXEO FY Change in Working CapitalUSD
LXEO FY Change in Working Capital2020-12-31: $150.15K2021-12-31: $6.04M2022-12-31: $1.79M2023-12-31: $1.48M2024-12-31: $2.73M2025-12-31: -$9.52M$6.04M-$9.52M
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-9,515,000
2,729,000
1,482,000
1,791,000
6,041,000
150,151

Compare change in working capital

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.